Study Objectives: To determine the effects of changes in nocturnal sleep and daytime nap durations on all-cause mortality among older adults.
Introduction
Multiple studies have shown that sleep duration plays an important role in mortality risks among older adults. While long sleep duration at night has consistently been linked with an elevated risk of all-cause mortality, associations of short sleep have also been documented [1] [2] [3] [4] [5] . However, in most existing studies, sleep duration was assessed at a single time point only. Given that sleep duration may vary across time [6] , the role of change in sleep duration warrants investigation. Indeed, dramatic changes (both increases and decreases) in sleep duration have been found to elevate the risk of all-cause mortality [7, 8] . Notably, in some of these studies, participants were required to report their sleep duration over a 24-hour period and thus, daytime napping was also included [9] [10] [11] , suggesting the possibility that changes in nap behavior over time may also influence mortality risk.
Daytime napping is prevalent among older adults worldwide particularly in China, Latin America, and Mediterranean countries [12] [13] [14] . Previous studies have shown that compared with non-nappers, nappers face a higher mortality risk, and this relationship appears to be dose-dependent with increasing mortality risk for those who nap longer [12, 15, 16] . However, the impact of change in nap duration on mortality remains to be investigated.
Here, utilizing longitudinal data from a nationally representative sample of community-dwelling older adults in Singapore, we investigated the contribution of change in self-reported nocturnal sleep duration and change in self-reported daytime nap duration to all-cause mortality. Based on existing findings [7] , we hypothesized that progression to long sleep and reduction to short sleep at night would both increase mortality risks relative to consistently sleeping for the recommended durations of 7 to 8 hours [17] . In line with the adverse impact of long naps previously reported [15] , we also postulated that compared with those who had never napped, elderly who reported an increase in nap duration, or consistently napped for either short or long durations would face higher mortality risks.
Methods

Participants
Data came from a nationally representative longitudinal survey (Panel on Health and Ageing of Singaporean Elderly [PHASE]), which documents the psychological, social, behavioral, and health conditions of community-dwelling older adults in Singapore. Information on the mortality status, including date of death of the deceased, until end-December 2015 was obtained from the national Registry of Births and Deaths databases. PHASE Waves 2 and 3, analysis of de-identified data from PHASE Wave 1, and linkage with the deaths databases were approved by the institutional review board at the National University of Singapore. Details of data collection at baseline (2009) are available elsewhere [18] . Briefly, a single-stage stratified (by age, sex, and ethnicity, based on the 2007 population distribution) random sampling method was adopted to recruit participants aged 60 years or above. After informed consent, 4990 face-toface interviews were conducted in the participants' residence, and, of these, 4473 participants reported their nocturnal sleep and daytime nap durations. Three-hundred fifty-seven individuals had died between baseline and the 2-year follow-up. At the 2-year follow-up, 3103 interviews were conducted, and, of these, 2715 participants reported their sleep and nap durations. There were 2448 older adults who reported their sleep and nap durations at both time points. They did not have any missing data on the covariate variables ( Table 1) . None of these individuals had been diagnosed with dementia (self-reported and/or confirmed with household members). Sample characteristics by sleep and nap duration categories at baseline are shown in Supplementary Tables S1 and S2, respectively. For attrition analysis, we evaluated whether the analytical sample (n = 2448) and those who reported nocturnal sleep and daytime nap at baseline (n = 4473) were similar in terms of baseline sleep and nap durations as well as covariates [19] . Results showed that attrition was not a serious concern (η 2 s ≤ 0.01), suggesting that the analytical sample mirrored the population of this age group in 2007.
Self-reported nocturnal sleep and daytime nap durations
Participants indicated their nocturnal sleep duration in hours and minutes by answering the question "On average, approximately how much do you sleep per night?" Fractional hours were coded as rounded integers (e.g. 7 hours represented 6.5 hours to 7.4 hours) [20] . Participants were classified into three categories at each phase based on the sleep duration recommendation for older adults by the National Sleep Foundation [17] : recommended (7-8 hours), short (≤6 hours), and long (≥9 hours) durations. Operationally, the three groups consisted of individuals reporting nocturnal sleep durations of 6.5-8.4 hours, ≤6.4 hours, and ≥8.5 hours, respectively. Following previous work N and % are shown except for age (years), social networks, depressive symptomatology (scale score ranges = 0 to 60 and 0 to 22 respectively, with higher scores indicating higher levels of the constructs), and body mass index. [7, 10, 11] , we created nine categories of change (including no change) in nocturnal sleep duration from baseline to the 2-year follow-up to represent all possible combinations of change. Similarly, participants indicated their daytime nap duration in hours and minutes, and they were classified into three categories at each phase [15] : none, short (≤1 hour), and long (>1 hour) durations. Using all possible combinations, nine categories of change (including no change) in daytime nap duration were constructed.
All-cause mortality
All-cause mortality, until end-December 2015, was assessed primarily from the national Registry of Births and Deaths databases, supplemented by our survey data. 274 individuals (11.2%) in our sample had passed away in the approximately 4-year period from their interview date in the 2-year follow-up to endDecember 2015.
Covariates
Covariates included nine sociodemographic and 10 health variables. All covariates were self-reported, except height and weight. The sociodemographic covariates were age, sex, ethnicity, education level, housing type, employment status, marital status, living alone, and social networks with friends and relatives outside the household. Housing type is an indicator of socioeconomic status in Singapore (≥4 room public/private indicates a relatively high status). "Married" included those not living with their spouse due to one spouse's being hospitalized, living in an institution, or living in another area for business reasons or to take care of others. "Unmarried" included those widowed, separated from spouse, divorced, and never married. Social networks were assessed with the 12-item modified Lubben's social network scale (scores ranging from 0 to 60) [18] . Health covariates included depressive symptomatology (the 11-item Center for Epidemiological Studies Depression [CES-D] Scale with scores ranging from 0 to 22) [21] . Physical exercise referred to frequency (less than 1 month vs. at least once a month) of physical exercise (walking for exercise purposes, playing a game of sport), and smoking was captured as "current smoker" versus "ex-/nonsmoker" [22] . In addition, participants reported whether they had ever been diagnosed by a medical professional with heart attack, other heart condition, cancer (excluding skin cancer), cerebrovascular disease, high blood pressure, and diabetes. Body mass index (BMI) was calculated using measured weight and height.
Statistical analysis
Using SPSS version 24, we conducted Cox proportional hazards regression analysis to estimate the associations (hazard ratio; HR) of changes in nocturnal sleep duration and daytime nap duration between baseline and the 2-year follow-up with all-cause mortality in the subsequent 4 years. Following the statistical approach used in previous studies [7, 10, 11] , we investigated change in sleep duration and mortality based on 9 categories of change, with participants reporting the recommended sleep duration at both phases as the reference group. Regarding nap duration change, consistent with our approach for analyzing sleep duration change, as well as our hypothesis about the impact of nap duration change, participants who did not nap at both phases were used as the reference group. Overall, we included all the dummy variables for change in sleep duration and change in nap duration in the same statistical model to assess the unique contribution of each parameter. The proportionality assumption was evaluated with a standard procedure which concerns the interaction between time and the study variables [23] . Results indicated that this assumption was met. In the adjusted model, covariates (including the linear and the quadratic terms of BMI) assessed at baseline, together with change in health-related factors between baseline and the 2-year follow-up, were taken into account [7] . Sensitivity analysis showed that results remained similar when outliers (cases with standardized sleep and/ or nap durations exceeding |3.29| [23] at baseline and/ or 2-year follow-up) were excluded. Thus, here, we focus on the findings based on 2448 individuals (with the outliers included).
The main analysis outlined above represents a planned comparison (recommended-recommended as the reference category for change in sleep duration, and none-none as the reference category for change in nap duration), in which sleep and nap durations were treated as categorical variables. To preserve the continuous nature of these variables, we conducted a supplementary analysis-multivariable fractional polynomial regression which provides a flexible parameterization for continuous variables to capture nonlinear associations with the outcome of interest-with Stata package MFPIgen [24] . Interaction terms are omnibus and have been argued to be less informative and important than the results of planned comparisons [25, 26] . Hence, the interaction effect between sleep duration at baseline and the 2-year follow-up, as well as that between nap duration at baseline and the 2-year follow-up revealed by the multivariable fractional polynomial regression would not be underscored here. On the other hand, the respective sliced plots [24] are provided to substantiate the main analysis.
Results
Change in nocturnal sleep duration
The findings of the unadjusted and adjusted Cox regression models were similar (Table 2 ). In the adjusted model, relative to older adults who reported the recommended sleep durations at night at both phases, all-cause mortality risk in the subsequent 4 years increased by 114% (HR = 2.14, 95% confidence interval [CI 95 ] = 1.12, 4.11; Supplementary Figure S1 ) in those whose sleep duration increased from short to long, and by 156% (HR = 2.56, CI 95 = 1.22, 5.37) in those whose sleep duration decreased from long to short over 2 years. Also, older adults who reported long sleep durations at both time points had a 124% higher risk in mortality (HR = 2.24, CI 95 = 1.05, 4.77). A similar pattern was found when sleep durations (and nap durations) at baseline and the 2-year follow-up were used as continuous variables in a multivariable fractional polynomial regression (Supplementary Figure S3) .
Change in daytime nap duration
Compared with their counterparts who did not nap at both baseline and the 2-year follow-up, the risks for all-cause mortality were significantly increased in older adults who did not nap at baseline but reported napping at the follow-up (HR = 1.86, CI 95 = 1.26, 2.75 for short nap at follow-up; HR = 1.91, CI 95 = 1.06, 3.45 for long nap at follow-up) ( Table 2 ; Supplementary Figure S2) . A significantly higher risk was also observed for older adults whose nap duration extended from short to long within the 2-year period (HR = 2.16, CI 95 = 1.32, 3.53). Overall, any increase in nap duration was associated with a higher mortality hazard.
Out of the three groups that reported a decrease in nap duration from baseline to follow-up, only the long-short group had a significantly higher mortality risk (HR = 1.86, CI 95 = 1.10, 3.13). In contrast, risks were not elevated for individuals who no longer took naps at follow-up, regardless of their nap duration at baseline.
Finally, increased mortality hazards were observed in older adults who had napped for consistent durations across the two phases. Persistently napping for short durations elevated mortality risk by 49% (HR = 1.49, CI 95 = 1.01, 2.21), while napping for long durations at both baseline and follow-up entailed a 168% increase in all-cause mortality risk (HR = 2.68, CI 95 = 1.69, 4.23). The pattern revealed by the multivariable fractional polynomial regression, in which nap durations (and sleep durations) at both time points were included as continuous variables, mirrored these findings (Supplementary Figure S4) .
Discussion
Using a nationally representative sample of older adults in Singapore, we have replicated earlier findings that all-cause mortality risk is elevated among older adults whose selfreported nocturnal sleep duration dramatically increases or decreases, or remains long over time [7, 8, 11] . More importantly, we report for the first time that change in daytime nap duration also impacts all-cause mortality risks. Specifically, relative to non-nappers, all-cause mortality risks in the subsequent 4 years are elevated in older individuals whose nap durations have increased in the 2-year study period either from short to long or because they have started napping, as well as older adults whose nap durations have decreased from long to short. Furthermore, older adults who have napped for similar durations at both time points (i.e. the short-short group and the long-long group) face elevated mortality risks. In other words, daytime napping is accompanied by increased mortality risks unless napping has stopped. Our observations are in line with previous studies that measured nap duration at only one time point and showed a positive relationship between nap duration and all-cause mortality risk [15] .
Daytime napping and nocturnal sleep may share similar mechanisms in their associations with mortality [27] . For example, levels of inflammatory markers, such as interleukin-6 (IL-6) and C-reactive protein (CRP) have been found to increase in individuals who have restricted sleep at night [28, 29] , as well as those who report long nocturnal sleep durations [30] . Also, daytime napping is associated with higher levels of CRP in older adults [31] . Hence, extreme nocturnal sleep durations and long daytime nap duration might both increase risks for all-cause mortality via chronic low-grade inflammation. Furthermore, extreme nocturnal sleep durations and daytime napping have been linked with medical conditions such as hypertension [32, 33] , diabetes [32, 34] , and coronary heart disease [27, 35] . While extreme nocturnal sleep durations and daytime napping may increase risks of these medical conditions, they can also be markers of poor physical health which elevates mortality risks [36] [37] [38] [39] .
The similarity in biological mechanisms suggests the possibility that daytime napping affects mortality risks because it is a consequence of poor nocturnal sleep quality, sleep disturbance at night (e.g. difficulties in initiating or maintaining sleep, the use of sleep medication), and sleep disordered breathing which have been reported to increase mortality risks [40] [41] [42] . Furthermore, even in healthy older adults, changes in the circadian rhythm can alter both sleep and nap patterns. Specifically, the age-related weakening in the circadian sleep-promoting signal in the early morning can lead to fragmented nocturnal sleep [43] , while the age-related weakening in the circadian arousal signal during the daytime increases levels of sleepiness and causes older adults to fall asleep more readily [44] . Thus, it may not be daytime napping per se that is associated with risks for mortality. However, critically, in this study, change in nocturnal sleep duration and change in daytime nap duration were included into the same statistical model, and various medical conditions were included as covariates. Thus, change in daytime nap duration did significantly contribute to mortality risk independent of any influence of change in nocturnal sleep duration, as well as the medical conditions we investigated. It is important to note that similar to previous findings [45] , in our sample, the associations between sleep and nap durations at baseline (r = −0.01) and the 2-year follow-up (r = −0.03), as well as between changes in sleep and nap durations (r = −0.04), were negligible, further strengthening the possibility that change in nap duration uniquely influences all-cause mortality risks. A few limitations need to be acknowledged. First, we only examined the importance of self-reported nocturnal sleep and daytime nap durations. Since discrepancies exist between objective and self-reported sleep durations [46] , future studies should determine if findings are similar when sleep and nap durations are evaluated by actigraphy and polysomnography. Also, we did not address the contribution of other sleep features, such as sleep quality and architecture, as well as sleep apnea, to mortality risks which should be studied in the future. Second, in our survey, participants were not required to indicate their reasons for napping. Nevertheless, we acknowledge that implications can vary across voluntary naps and naps due to some underlying pathologies. Third, while we controlled for the potential influence of multiple pre-existing medical conditions (e.g. cancer and cerebrovascular disease), these were based on self-report and might involve broad categorizations (e.g. other heart conditions). Also, it remains possible that the associations of sleep and nap changes with all-cause mortality risk could be due to medical problems we did not investigate, as well as the use of sleep-inducing medications. Another caveat concerns the small size and low death counts of some cells which were associated with small power, and did not allow subgroup analysis for examining the potential moderating effects of age and sex. In addition, since the relevant information was not available, we could not differentiate causes of death which should be addressed in future studies.
In conclusion, we have shown for the first time that in addition to change in nocturnal sleep duration, pattern of daytime nap duration over time can also predict all-cause mortality risk in older adults. These findings indicate the importance of tracking older adults' sleep and nap durations longitudinally.
